Citizens Jmp upgraded shares of U.S. Physical Therapy (NYSE:USPH - Free Report) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.
Several other research firms have also recently issued reports on USPH. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $100.00 to $115.00 in a report on Monday. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st. JMP Securities started coverage on shares of U.S. Physical Therapy in a research note on Monday. They set an "outperform" rating and a $113.00 price objective for the company. Barrington Research reissued an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, JPMorgan Chase & Co. boosted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $114.00.
View Our Latest Stock Report on U.S. Physical Therapy
U.S. Physical Therapy Trading Down 2.7 %
NYSE USPH traded down $2.55 during mid-day trading on Monday, reaching $92.43. 124,566 shares of the stock were exchanged, compared to its average volume of 93,961. The stock has a market capitalization of $1.40 billion, a PE ratio of 98.33, a PEG ratio of 4.23 and a beta of 1.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The business's fifty day simple moving average is $90.02 and its 200 day simple moving average is $89.80.
U.S. Physical Therapy Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a $0.44 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.90%. U.S. Physical Therapy's dividend payout ratio (DPR) is 187.23%.
Insider Activity
In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 2,000 shares of the business's stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $95.84, for a total transaction of $191,680.00. Following the completion of the transaction, the insider now directly owns 14,814 shares of the company's stock, valued at $1,419,773.76. The trade was a 11.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Carey P. Hendrickson sold 516 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,412 shares of company stock valued at $706,605 in the last three months. Corporate insiders own 1.70% of the company's stock.
Institutional Investors Weigh In On U.S. Physical Therapy
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Precision Wealth Strategies LLC grew its position in U.S. Physical Therapy by 5.1% in the 3rd quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company's stock valued at $239,000 after buying an additional 137 shares in the last quarter. First Horizon Advisors Inc. lifted its stake in shares of U.S. Physical Therapy by 18.6% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company's stock worth $110,000 after acquiring an additional 186 shares during the period. Louisiana State Employees Retirement System boosted its holdings in shares of U.S. Physical Therapy by 2.7% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company's stock valued at $702,000 after acquiring an additional 200 shares in the last quarter. Martin Capital Advisors LLP boosted its holdings in shares of U.S. Physical Therapy by 1.6% in the third quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company's stock valued at $1,112,000 after acquiring an additional 201 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy during the second quarter valued at approximately $28,000.
About U.S. Physical Therapy
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Recommended Stories
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.